Applied

Type

Modification

Confidence

90%

Created

Mar 19, 2026

Evidence

2 sources

Rationale

The integration incorporates the latest 2025 ACC Scientific Statement on diabetic PAD, which highlights the specific diagnostic challenges posed by medial calcification. It also adds a modern value-based medicine perspective from Raskin et al. (2025) to guide clinicians in appropriate imaging selection, emphasizing that cross-sectional and invasive imaging should be reserved for patients where the results will directly influence revascularization decisions. Abbreviations were expanded on first use as per instructions.

Content Changes

<!-- type: diagnostic -->
**Imaging Modalities for peripheral arterial disease (PAD)**

| **Modality** | **Indications** | **Advantages** | **Limitations** |
| --- | --- | --- | --- |
| **Duplex Ultrasound**Ultrasound (DUS)** | First-line screening | No radiation/contrast, PSVpeak systolic velocity (PSV) ratios | Operator-dependent, limited by calcification [@acc2025-management] |
| **computed tomography angiography (CTA)** | Surgical planning | Detailed anatomy, fast | Contrast, radiationradiation, calcium blooming artifacts [@acc2025-management] |
| **magnetic resonance angiography (MRA)** | Contrast allergy, chronic kidney disease (CKD) | No radiation | Longer scan time, overestimates stenosis |
| **digital subtraction angiography (DSA)** | Intra-procedural | Gold standard, therapeutic | Invasive, contrast |

* **Duplex Ultrasound:**Ultrasound (DUS):** first-line imaging modality; uses peak systolic velocity (PSV)PSV ratios to grade stenosis severity (PSV ratio >2.0 indicates ≥50% stenosis).[@moneta2010] In patients with diabetes, medial arterial calcification can significantly limit the accuracy of DUS due to acoustic shadowing [@acc2025-management].
* **Computed Tomography Angiography (CTA):** provides detailed anatomic mapping of the entire arterial tree; preferred for planning revascularization in most patients.[@ahaacc2016] To ensure value-based care, CTA should be reserved for patients where revascularization is clinically indicated to avoid imaging misallocation [@raskin2025].
* **Magnetic Resonance Angiography (MRA):** alternative cross-sectional imaging when CTA is contraindicated (renal insufficiency, contrast allergy); gadolinium-based agents carry lower nephrotoxicity risk.[@prince2016]
* **Digital Subtraction Angiography (DSA):** intra-procedural gold standard for anatomic assessment; allows simultaneous diagnosis and therapeutic intervention.[@white2006] DSA is generally not recommended for primary diagnosis alone when non-invasive options are available [@raskin2025]. See [[Diagnostics in Vascular Surgery|Chapter 3]] for comprehensive imaging principles.